- Home
- OBE vs THW Comparison
OBE vs THW Comparison
Compare OBE & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | OBE | THW |
|---|---|---|
| Founded | 1979 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Finance Companies |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.9M | 513.9M |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OBE | THW |
|---|---|---|
| Price | $9.58 | $12.55 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 907.2K | 88.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.88 | $10.10 |
| 52 Week High | $9.81 | $13.19 |
Technical Indicators
Market Signals| Indicator | OBE | THW |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 63.19 |
| Support Level | $5.57 | $12.33 |
| Resistance Level | $9.81 | $12.95 |
| Average True Range (ATR) | 0.40 | 0.27 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 76.98 | 94.70 |
Price Performance
Historical ComparisonAbout OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Sale of Oil.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.